MSD’s Keytruda-Padcev combo secures EC approval for MIBC
The approval is based on results from the KEYNOTE-905/EV-303 trial, conducted in partnership with Pfizer and Astellas.
Drug Development
RQ Bio secures $115m to develop influenza antibody programme
Boehringer and Combotope partner for cancer antibodies
Haisco and Nuvectis sign licensing deal for two drugs
Genprex’s Reqorsa combo secures Canadian patent for lung cancer
Lilly and BioArctic sign deal to develop neurodegenerative therapy
Sun Pharma to acquire Innovcare Lifesciences for $28.7m
Japan approves Sanofi’s Sarclisa combo for MM treatment
